From Name:
From Email:
To Name:
To Email:

Optional Message:

AstraZeneca Spreads Its Virtual Reach To Cardio R&D With New Partnership

from FierceBiotech

AstraZeneca is expanding iMed, its virtual R&D project, through a cardiovascular-focused agreement with Germany's Max Planck Institute of Molecular Physiology that will focus on early-stage research. Under the agreement, scientists at AstraZeneca's iMed satellite outpost in Mölndal, Sweden, will work alongside Max Planck researchers to study new modalities in chemistry such as stabilized peptides, macrocycles and conjugation chemistry, the partners said. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063